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Abstract 
The Surveillance of Cerebral Palsy in Europe (SCPE) network was established in 
1998, bringing together professionals and researchers working in population-based 
registries of children with Cerebral Palsy (CP) across Europe. The aims of the 
network are to collect population data on CP to inform and improve understanding 
of the disease, to raise standards of care for children with CP, disseminate knowledge 
for patients, health care professionals and key stakeholders, and to provide a 
framework for collaborative research.  
In 2016, to provide sustainability for this very important network, the SCPE Central 
Registry and European level coordination activities were transferred to the JRC and 
became part of the European Platform for Rare Diseases Registration. The SCPE 
Central Database is annually updated with new cases submitted by the SCPE 
Registries.  
In line with the mission of the JRC for providing evidence-based policy support, and 
in order to extend the use of the SCPE Central database to public health relevant 
outputs, the JRC-SCPE Central Registry launched the initiative of developing public 
health indicators. The public health indicators have been developed by based on 
collaboration between the JRC and the University Hospital of Toulouse. The input 
for the calculations of these indicators is based on data included in the standard 
SCPE dataset and collected annually by the registries in the JRC-SCPE Central 
Database.  
The current report describes the development of the JRC-SCPE Central Database 
after the transfer from the University of Grenoble, and the definition of a first set of 
key health indicators.  
  
 4 
  
 5 
1 Introduction 
Cerebral palsy (CP) is the leading cause of early-onset physical disability that has a 
lifelong impact for the individuals and their families. Its relatively uncommon 
occurrence, its various clinical patterns, the fact that causal pathways are still 
unknown in many cases, make it a complex condition to study and emphasize the 
need for studying populations of large size. Population-based registries and 
networks of registries play an important role in this, and allow to better understand 
the burden of the condition at population level, examine variations in clinical 
practice and access to care, raise standards of care for children with CP, provide 
information for education and resource planning, and disseminate knowledge to 
health professionals, policy makers, patients and families. 
In the framework of implementing European Commission’s strategy in the field of 
rare diseases, the Directorate-General Joint Research Centre (JRC) and the 
Directorate-General for Health and Food Safety (DG SANTE) signed in December 
2013 the Administrative Arrangement (AA) on the ‘Development and Maintenance 
of the European Platform on Rare Diseases Registration’. One objective of the AA 
was the transfer of the European-level coordination activities and the Central 
database of SCPE to the JRC. 
SCPE is a network of population-based registries for the surveillance of cerebral 
palsy (CP) active since 1998. Currently it has 31 members in 23 EU/EFTA countries, 
out of which 23 members are actively providing data to the Central Registry (Fig. 1).  
In order to offer a sustainable solution for the continuation of the SCPE activities, to 
secure the results of former work and to keep the network functioning, it was agreed 
that SCPE becomes part of the European Platform for Rare Diseases Registration 
being developed at the JRC, since the diseases/conditions it deals with belong to the 
category 'rare'. 
The JRC-SCPE Central Registry is located in the Health in Society Unit (JRC.F.1, 
Ispra, Italy). The role of the Central Registry is to maintain and further develop the 
SCPE Central Database, securely manage the data from all registries, and analyse the 
data with respect to data quality. The Central Registry also supports and participates 
in the coordinating activities of the network, by maintaining regular contact with 
single registries and organisation of meetings (annual network meetings, 
Management Committee and various Working Groups). Moreover, the Central 
Registry has an important role in the dissemination of the network's results through 
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scientific reports and publication of relevant information on the JRC-SCPE website 
(currently under development). 
 
Figure 1. Map of the SCPE network, including active [•] and past [•] member registries and 
the JRC-SCPE Central Registry.  
 
SCPE promotes quality and harmonization of CP definition/description. The SCPE 
Central Database is the collection of anonymised data submitted by SCPE Registry 
members in a standardised way, checked and validated by the Central Registry. The 
SCPE Central Database was transferred to the JRC in 2016 and SCPE member 
registries submit annually new cases to the JRC-SCPE Central Registry. The database 
contains about 20.000 cases of children with CP, covering the live-birth period 1976-
2008. 
Using the data collected in the JRC-SCPE Central Database, the network develops 
collaborative epidemiological and clinical research about CP, disseminates 
knowledge for patients, health care professionals and key stakeholders, develops 
best practice in monitoring trends in CP and raises standards of equitable care for 
people with CP. All this improves outcomes for individuals with CP.  
Until now SCPE network concentrated mainly on its epidemiological and clinical 
research. However, the SCPE Database is also a valuable resource that can potentially 
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provide evidence-based information to policy makers to facilitate provision of 
appropriate, accessible, cost-effective care management programmes aimed to 
improve the quality of life for children and young people with CP and for their 
caregivers.  
Public health indicators are increasingly developed for many conditions to inform 
planning, action and reporting, and overall serve as a basis for policy-making to 
improve the health at the population level. They are at the intersection of health 
policy issues and routinely collected datasets. They must be monitored on a 
systematic basis, regularly reported, using a consistent set of data that reflects the 
whole scope of the condition, and over time thus identifying any trend. Consistent 
with this, the public health indicators may assist in determining what the research 
priorities are.  
The current report describes conceptual definition of a first set of public health 
indicators that have been developed based on collaboration between the JRC and the 
University Hospital of Toulouse. The input for the calculations of these indicators 
will be based on data included in the standard SCPE dataset and collected annually 
by the registries in the JRC-SCPE Central Database.  
The SCPE public health indicators are intended to be useful descriptive tools for a 
better understanding of the condition, for monitoring the heath of the population of 
children with CP, and for addressing their main determinants. They are designed to 
show differences between registries that could reflect the complex interactions 
between social and economic factors, the physical environment, the access to care 
and individual behaviours and living conditions. These indicators are the first step to 
invite actions for implementing programs and service deliveries for improvement of 
the children’s condition and life when growing and aging.  
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2 The evolution of the JRC-SCPE Central 
Database 
The added value of the SCPE network of registries comes from the pooling of 
standardised data into the Central Database to perform monitoring and research 
activities. The operation of the Central Database includes all activities aimed at 
strengthening the value and quality of the database. This comprises, among other 
functions, maintaining the database, updating it annually with data submissions 
from registries, and extending the network of data providers. 
The SCPE Central Database has been transferred from the Centre in Grenoble to the 
JRC in December 2016. In 2016 the JRC-SCPE Central Registry performed several 
activities to enable full functionality of Central Database at JRC, including the 
formalisation of the collaboration agreement with all registries, set-up of the secure 
JRC-SCPE IT infrastructure and notification to the Data Protection Officer.  
2.1 Management of the Central Database 
The Central Database was transferred from the Centre in Grenoble in an Ms Access 
file format containing data collected from the registries and variables derived from 
them. At the moment of the transfer, the database contained 17.372 cases collected 
since 1998 (until the birth year 2006), as well as the denominators for all active 
registries.  
After the transfer of the Central Database the JRC-SCPE Central Registry contacted 
all registries of the network in order to check that all the data were present and in 
line with the local datasets. In April 2017 a general update of the different types of 
denominators used for the analysis of the data was also performed. Not all the 
registries are able to collect locally all the type of denominators, while it is possible 
for the registries that have a national coverage (Table 1).  
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Table 1.  Percentage of SCPE active registries (18) which have the different types of 
denominators. 
Denominator type % of SCPE active registries 
Total births 100% 
Delivery mode 50% 
Delivery mode (by birth weight) 44% 
Delivery mode (by gestational age) 44% 
Place of birth 72% 
Maternal age and parity 94% 
Neonatal death (by birth weight) 67% 
Neonatal death (by gestational age) 67% 
Neonatal death Multiple (by birth weight) 56% 
Neonatal death Multiple (by gestational age) 56% 
Livebirth (by birth weight) 83% 
Livebirth (by gestational age) 72% 
Livebirth Multiple (by birth weight) 61% 
Livebirth Multiple (by gestational age) 61% 
 
Before the transfer of the entire database, between June and September 2016 the JRC-
SCPE Central Registry managed the first data submission campaign. Thirteen SCPE 
registries participated in the data submission campaign and a total of 1503 cases were 
sent to the JRC. Registries transmitted data through the JRC-SCPE data transmission 
portal. The data collected were then validated in collaboration with the previous 
Central Registry team in Grenoble. 
At the beginning of the 2017 the validated data were imported in the Central 
Database and a first feedback performed by the Central Registry. Figure 1 shows the 
status of the Database in May 2017. 
2.2 Management of the data submission campaigns for the 
birth year 2008 
To achieve the main purpose of surveillance of cerebral palsy in Europe, the Central 
Database needs to be regularly updated by registry members. The SCPE network 
established a calendar with one annual data collection campaign, during the spring 
time. The data are collected based on a set of variables defined in the “Guideline for 
data submission” developed by the network. This is a guidance document aimed at 
enabling registers to prepare files of CP cases and population-based denominators to 
be submitted to the SCPE common database, in accordance with the SCPE agreed 
definition and inclusion criteria, the predefined format for the requested items.  
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After the data are submitted to the Central Registry, data checks and validation 
follow and "feed-back to registries" documents are prepared and discussed during 
the Annual Plenary meeting usually taking place in October-November.  
The new data collection for the birth year 2008 was performed between April and 
July 2017. In view of the development of a first set of Public Health Indicators that 
will be used to also for a routine evaluation of the CP data collected by the registries, 
many centres preferred to update their data for the previous years and re-align the 
Central Database with the local data. The following registries submitted and 
validated the data for the birth year 2008: C02 (Toulouse, France), C06 (Sweden), C07 
(Dublin, Ireland), C13 (Italy), C21 (Portugal), C22 (Riga, Latvia), C23 (Hungary), C25 
(Iceland), C28 (Croatia), C29 (S. Gallen), C31 (Greece). In addition, C01 (France, 
Grenoble) and C23 (Hungary) sent data for 2007, C27 (Belgium) sent new cases for 
2007, and C15 (Norway) updated data with new cases for the period 1998-2007. 
Figure 2 shows the status of the JRC-SCPE Central Database in October 2017. 
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Figure 2. JRC-SCPE Central Database in May 2017: number of cases per year and registry. In green data collected at the JRC during the 2016 
data submission campaign. 
 
 
Figure 3. JRC-SCPE Central Database in October 2017: number of cases per year and registry. In green data collected in 2016 campaign an in 
orange data collected in 2017 campaign at the JRC. 
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2.3 Feedback to the registries on the data submitted 
After the data submission campaign, a feedback report for every registry was 
prepared by JRC-SCPE Central Registry in collaboration with the Centre in Grenoble, 
based on the procedures used until now by SCPE network and described in the 
Standard Operating Procedure n˚6 “Feedback to the registries and network”.  
The objective of this report is to provide in a systematic way comment to the 
registries that during the last data submission campaign sent data to the JRC-SCPE 
Central Registry. It is the main instrument for the registries to identify possible 
problems and areas for improvement in the data collection, and for the SCPE Data 
and Scientific Working Groups to evaluate if a given variable has a good coverage in 
order to be used for data analysis and in research studies.  
The template for the feedback report (Annex 1) has been updated by the Central 
Registry adding information on the unknown/not collectable data rates, and reports 
distribution of key variables, prevalence rates of a given registry in comparison with 
data previously submitted by the same registry, as well as data submitted by other 
registries during the same campaign.  
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3 Definition of SCPE Public Health Indicators 
The SCPE public health indicators aim to summarize important aspects of the public 
health impact of CP. They enable to make comparisons between countries/registries 
and over time. They are reported in six measures based on reliable and comparable 
data compiled in the JRC-SCPE Central Database after thorough harmonisation and 
validation processes. 
The SCPE public health indicators are defined to evaluate the following four areas:  
 Long-term child health outcomes: Birth prevalence rate of CP, a 
recommended EuroPERISTAT indicator1; 
 Burden of disease: Type of motor function disorder, walking ability, and birth 
prevalence rate of severe cases of CP; 
 Access to facilities/services: Proportion of children who have had 
neuroimaging; 
 Preventive health strategies:  Prevalence and severity of CP cases with post-
neonatal origin. 
3.1 Birth prevalence of cerebral palsy 
This indicator relates to pre- or perinatal cases of CP (a case of CP with a known 
post-neonatal cause is excluded). It is split into birth prevalence and trend in birth 
prevalence, both per 1,000 live births. 
The number of people affected in the population is a measure of long term 
consequences of perinatal complications, relevant to better understand the 
effectiveness of the organisation of perinatal care and practices. Cerebral palsy has 
been a recommended EuroPERISTAT indicator for long-term child health outcomes 
since 2007, especially as mortality rates can no longer reflect standards in perinatal 
care accurately in view of the improved survival rates. 
3.2 Type of motor function disorder 
The distribution of the type of motor function disorder reflects the predominant 
motor function pattern. It shows the frequency of bilateral (bilateral spastic, 
dyskinetic) and unilateral (unilateral spastic) forms. It serves as an indicator of 
severity and therefore burden of disease. 
                                           
1 http://www.europeristat.com/our-indicators/indicators-of-perinatal-health.html 
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3.3 Walking ability 
Walking ability is defined according to the levels of the Gross Motor Function 
Classification System (GMFCS, a classification of the movement ability of children 
with CP), classifying the children into 3 categories as follows: ‘mild’ forms 
corresponding to GMFCS levels I-II (independent walker), ‘moderate’ forms with 
GMFCS level III (walker with aid), and ‘severe’ forms GMFCS levels IV-V 
(wheelchair). It serves as an indicator of burden of disease. 
3.4 Prevalence of severe cases of cerebral palsy 
The severity of CP is defined by severe impairment of the gross motor function 
(GMFCS III-V) or an associated cognitive impairment (defined by an intellectual 
quotient (IQ) <50). This indicator is split into prevalence and trend in prevalence of 
severe cases, both per 1,000 live births. It serves as an indicator of burden of disease. 
3.5 Access to neuroimaging 
Access to neuroimaging is defined by the proportion of children with CP who have 
had at least one MRI of the brain whatever the period when this imaging occurred 
(neonatal period i.e. before discharge from the neonatal unit, or post-neonatal period, 
usually after 2 years of age). There is an international consensus that neuroimagining 
is of great importance in the understanding of pathogenesis in relation to timing of 
brain insult, and to a lesser extent aetiology of the brain disorder. It helps 
understanding the deteriorated function. Access to neuroimaging serves as an 
indicator of access to health services. 
3.6 Prevalence and severity of cerebral palsy of post-neonatal 
origin 
This indicator relates to post-neonatally acquired CP, i.e. cases with an identified 
causal event independent of antenatal and perinatal periods (mostly after the 28th 
day of life) occurring before 24 months of age. This indicator is split into prevalence 
and prevalence of severe cases (severe cases are defined by GMFCS levels III-V or 
IQ<50) and is reported per 10,000 livebirths. Because the main underlying causes of 
brain lesions (infections, head injury, surgical complications) that occur post-
neonatally are potential targets for preventive actions, this is an indicator of 
preventive health strategies. 
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4 Procedures for Calculating the SCPE Public 
Health Indicators  
4.1 Definition of CP 
Cerebral Palsy is a group of permanent, but not unchanging, disorders of movement 
and/or posture and of motor function, which are due to a non-progressive 
interference, lesion, or abnormality of the developing/immature brain. This 
definition specifically excludes progressive disorders of motor function, defined as 
loss of previously acquired skills in the first 5 years of life. Children with hypotonia 
as the sole clinical feature and children with isolated spinal neural tube defects are 
excluded. 
In order to be included in the JRC-SCPE Central Database, cases must fulfil this 
definition. The diagnosis is made solely on the basis of clinical description, 
independent of pathology or aetiology. Five years is the optimal age for confirmation 
of diagnosis. However, cases are considered for inclusion in the JRC-SCPE Central 
Database if they fulfil the clinical criteria after their 4th birthday. Submitted to the 
JRC-SCPE Central Database are also i) children with a diagnosis of CP made after the 
age of 2 years but who died before this diagnosis can be reconfirmed (between 2 and 
5 years); ii) children lost to follow-up at the age of 5 years but with unambiguous 
diagnosis of CP after the age of 3 years. 
4.2 Source of data 
The data used include all cases of cerebral palsy from population-based registries 
participating in the SCPE network, covering either a part or the whole country. These 
registries provide annually anonymised data to the JRC-SCPE Central Database. 
Annual population data (live births the same year in the same catchment area) are 
available from the census or any official data population source. 
Registries with a small area covered (defined as an area with less than 3,000 live 
births per year) are removed for these analysis.  
In addition, for post-neonatally acquired CP, the population is restricted to registries 
which collect such data on a regular basis and with at least one case recorded during 
the three last years. Data for the indicators (prevalence by centre and overall, and 
distributions) presented here correspond to birth cohorts 2005 to 2007 that were 
submitted to the Central Database between 2014 and 2016. For the calculations of 
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trends in this report, 10 years were considered (birth-cohorts from 1998 to 2007). A 
test analysis was performed to assess the performance of the proposed indicators. 
The Table 2 reports the registries currently in the Central Database before application 
of any inclusion or exclusion criteria for indicators’ estimations.  
 
Table 2. SCPE registries, years and number of cases included in the test dataset.  
Centre Birth year 
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 
C01 – Grenoble, France 32 49 43 36 34 53 44 31   
C02 – Toulouse, France 18 34 21 31 22 26 20 27 24 19 
C05 – Northern ireland 69 54 47 65 41 65  59   
C06 – Sweden, Goteborg 32 41 51 54 40 52 45 50 56 53 
C07 – Iteland, Dublin 42 48 54 49 53 52 54 57 61 58 
C12 - Denmark 147 151 147 120 137 106 130 103 132 121 
C13 - Italy 20 1 4 1 4 5 4 5 3 1 
C15 - Norway 100 129 121 123 142 130 147 145 157 129 
C19 - Slovenia  49 47 43 38 30 49 38 43  
C21 - Portugal    238 181 193 163 168 157 137 
C22 - Latvia   11 10 11 16 10 15 11 9 
C23 – Hungary, Pecs  22 25 27 17 12 13 17 17  
C25 - Iceland 13 14 15 10 9 6 9 15 6 8 
C26 - Austria 10 11 14 13 18 6 13 9 12  
C27 – Belgium (Leuven, then 
whole country) 
 22 27 10 24 26 25 23 20 151 
C28 - Croatia      86 63 62 79 77 
C29 Switzerland, St Gallen 12 6 13 13 9 7 13 6 10 10 
C31 – Greece, Athens  35 39 61 64 50 82 43 45  
 
4.3 Data analysis 
Selection of cases 
For indicators 1 to 5, cases of CP with a post-neonatal onset are excluded (i.e. 
collected variable POSTNEON≠1). Indeed, for post-neonatally acquired CP, a causal 
event independent of antenatal and perinatal periods (mostly after the 28th day of 
life) occurring before 24 months of age can be identified. As noted above, indicator 
number 6 refers to post-neonatal CP solely. 
Prevalence calculations 
Prevalence of CP were calculated per 1,000 live births. Children whose mothers lived 
in an area covered by a registry at the time of birth were considered (exclusion of 
cases with collected variable BIRTH_RESID=2), except for French centres where the 
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children included lived in the area at time of ascertainment (exclusion of cases with 
collected variable REGIST_RESID=2). 
Prevalence rates are reported by centre, and overall. 
Given: 
Birth year i 
Centre j (j=1, …, J) 
Nb_CPi,j , the number of cases of CP year i center j  
LBi,j, the number of livebirths year i center j 
Prev_CPi,j,_ prevalence year i center j 
 
𝑃𝑟𝑒𝑣 𝐶𝑃𝑖,𝑗 =
𝑁𝐵 𝐶𝑃𝑖,𝑗  𝑥 1000
𝐿𝐵𝑖,𝑗
  
 
The prevalence for year i, all J centres together, is calculated as follows: 
 
𝑃𝑟𝑒𝑣_𝐶𝑃𝑖 =
1000 x ∑ 𝑛𝑏_𝐶𝑃𝑖,𝑗
𝑗
𝑗=1
∑ 𝐿𝐵𝑖,𝑗
𝑗
𝑗=1
 
 
Post-neonatally acquired CP are rare events (around 5% of cases) and therefore 
reported per 10,000 livebirths. The prevalence rate of CP with a post-neonatal origin 
is only presented at the EU level (by pooling all cases from relevant registries 
altogether) because of the low prevalence. 
In all cases, because registry data cover a given country in its entirety or part of it but 
not primarily chosen to be representative of the whole country, rates are presented 
without any confidence intervals. 
Prevalence rates are estimated 8 to 9 years after birth. This delay is explained by 
several elements whose effects are cumulative. Firstly, age at confirmation of 
diagnosis of CP is at least 4 years. Therefore, registration of children with CP in 
population-based registries cannot be considered before the age of 4-5 years. 
Secondly, time is needed for the registration and validation of cases at the local 
levels, before being reported to the Central Registry. 
Trends over time 
Assessment of time trends is done by pooling the data from all registries. Trends are 
reported over a 10-year period (birth-cohorts from 1998 to 2007 in the test dataset 
used in this report). The number of registries considered in the analyses potentially 
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differs across the period. To smooth out short-term fluctuations and facilitate the 
interpretation, prevalence is presented using a 3-year simple moving average. For 
year i (central value), an unweighted mean of prevalence rates for years i-1 to year 
i+1 is calculated. A line graph is proposed with all central values on the x axis (10 
birth cohorts, 8 points). 
Other indicators 
For the other indicators, the distributions by registry are presented in tables or bar 
charts as appropriate, representing 2005 to 2007 birth-cohorts’ data pooled together. 
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5 Development of statistical programmes 
for standardised calculation of the Public 
Heath Indicators 
The SCPE Public Health Indicators which will be part of the annual feedback to SCPE 
registries, and will be also published every year on the SCPE website. Therefore, the 
calculations of the indicators have been automatized. Two procedures were 
developed under the Stata software (Stata Data analysis and Statistical software, 
v14).  
The first procedure is used to prepare the data required for the calculations (CP cases 
as well as denominators) and to obtain the merged files in a correct format (for more 
details of the procedure see Annex 2).  
The second detailed Stata program serves to automatically calculate and report the 
indicators (tables and graphs) (for more details of the procedure see Annex 3).  
These two programmes will become the official procedure for the calculation of the 
SCPE Public Health indicators. They will be modified only after validation and 
approval of the JRC-SCPE Management committee.  
5.1 Data requested and creation of databases for calculations 
The program provided is the whole statistical reporting program for all centers. It 
requires the provision of the individual cases per registry collected in the JRC-SCPE 
Central Database in .txt format (statistical unit: CP case) and a database containing 
the denominators recorded in Stata (.dta) format. The database of the denominators 
must contain 3 variables named as follows: center, anais (birth of year), and livebirth. 
The names of the outputs (text output and graphics, saved as .wmf) as well as the 
directories can be modified by the user. From line “Do not modify the rest of the 
program file” in the Stata programs, the user no longer has to modify the program. 
The Stata program developed in order to prepare the databases creates six databases: 
‒ "$scpe_db prepared_$today": individual data on CP cases,  
‒ "scpe_aggregated_data prepared_$today": aggregated data (by year and registry), 
numerators and denominators, 
‒ "scpe_aggregated_data_pre_peri_10y_all prepared_$today": aggregated data (by 
year), numerators and denominators for pre-/peri-natal CP, 
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‒"scpe_aggregated_data_pre_peri_severe_10y_all prepared_$today": aggregated 
data (by year), numerators and denominators for severe pre-/peri-natal CP, 
‒ "scpe_aggregated_data_postneon_10y_all prepared_$today": aggregated data (by 
year), numerators and denominators for post-neonatal CP, 
‒ "scpe_aggregated_data_postneon_severe_10y_all prepared_$today": aggregated 
data (by year), numerators and denominators for severe post-neonatal CP,  
where "$scpe_db” refers to “SCPE individual data” and “$today” refers to “current 
date” ($scpe_dbet $today are global variables in the Stata programs). The name of the 
SCPE individual data is completed by the user at the beginning of the program, 
whereas the current date is computed by Stata. Because the current date is included 
in the name of the databases, the data preparation program and the data analysis 
program have to be applied on the same day. 
Finally, it is important to note that the Stata program has to be applied in its entirety, 
because it uses local variables.  
The Stata programs need version 14 of Stata with additional installation of two 
packages: 
- Stata "estout" package (http://repec.org/bocode/e/estout) is used to export two 
way contingency tables in text files, 
- Stata "sencode" package ((http://fmwww.bc.edu/RePEc/bocode/s/) is used to 
create the variable “centre_country”. 
Before starting the program, the user must complete the last year of birth to consider. 
For example, if the last year considered is 2007, the calculations will generate the 
indicators for 3 years corresponding to the 2005-2007 birth cohorts, and for 10 years 
corresponding to the 1998-2007 birth cohorts, according to the indicators. 
5.2 Content of the statistical program and exclusions from the 
calculations 
A summary of sampling variables created in order to identify the year of birth and 
registries included in the analyses is given. The exclusion of small registries is based 
on the number of live births in the area according to SCPE definition: less than 3,000 
livebirths on average during the last three years considered in the calculations. 
Exclusion criteria are summarized separately for each SCPE indicator. Thereafter, a 
list of registries included in each analysis is provided. The number of registries 
included in the trend analyses may differ according to birth of year; therefore, 
registries included in the analyses are reported by birth year. 
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Description of the proportion of missing/unknown values on the variables requested 
for analysis is also presented for information. ‘-99’ values correspond to not 
applicable i.e. for registries previously excluded from the analyses for a given 
indicator. The way missing values are considered in the analysis is precisely 
considered and defined for each indicator. As a general rule, registries that have a 
high proportion of missing/unknown data are excluded.  
For Public Health Indicator n°4 (Prevalence of severe cases), registries are removed 
from the analysis if the proportion of missing/unknown data for GMFCS and IQ 
level exceeds 10% for at least one birth-year (proportion estimated excluding post-
neonatal cases of CP). Considering Public Health Indicator n°5 (Access to 
neuroimaging), a higher threshold is retained: 30% of missing values in the derived 
variable over the 3 years. 
The definition of severity includes the GMFCS as a measure of walking ability (alone 
or in association with IQ level depending on the indicator). The inclusion of the 
variable “GMFCS” in the database was recommended from birth year 1997. The 
WALKING which is no longer collected in the SCPE database was maintained for 
registries which could not provide the GMFCS levels. Due to the date of this change, 
the program only considered the GMFCS variable as a measure of walking ability. 
However, for Public Health Indicator n°6 (Prevalence and severity of post-neonatal 
CP) and for the test provided here, due to the combination of the rarity of the 
condition and high levels of missing missing/unknown data for GMFCS, the 
prevalence of severe post-neonatally acquired CP is not presented. However, tables 
and graphics for severe post-neonatally acquired CP are prepared in the program 
file. 
The post-neonatal cases of CP are not routinely collected in all registries but this 
information is currently not easily identifiable. The current version of the program 
considered the registries for analyses when at least one case of post-neonatal CP is 
reported over the 3 last years considered. A clear distinction must be possible in the 
future (information at registry level). 
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6 Testing of the SCPE Public Health 
Indicators calculations 
In order to validate the indicators previously defied, the Central database was used 
to perform a testing analysis reported below. Birth year 1998 – 2007 were considered.  
As every publication of data from the SCPE network must be validated by the 
registries and the JRC-SCPE Management Committee, “sensitive” numbers are not 
reported.  
6.1 Birth prevalence of cerebral palsy 
The birth prevalence rate of cerebral palsy has been a recommended EuroPERISTAT 
indicator for long-term outcomes since 2007. It provides additional information on 
childhood health across the countries.  
This indicator is presented as both: 
 Birth prevalence rate of pre-/perinatally cases of CP per 1,000 live births by 
country over a 3-years period 
 10-years trend of birth prevalence rate of pre-/perinatally cases of CP per 
1,000 livebirths and per year for all the registries altogether. 
To calculate the birth prevalence rate only pre- and perinatal cases of CP 
(approximatively 95% of the cases) are included. Post-neonatally acquired cases (i.e. 
POSTNEON≠1) are excluded. The rates of pre- and perinatal cases of CP are 
calculated per 1,000 live births over a 3-year period. No confidence intervals are 
estimated.  
The population considered includes only registries with a covered area with 3,000 or 
more livebirths on average during the last 3-years. Population data (livebirths) are 
available for the corresponding centres/years.  
A Table in the form reported in Table 3 will show the prevalence of CP per 1,000 
livebirths across SCPE registries for children born a 3-years period.  
In the results of the testing analysis there were wide variations in prevalence 
between centres. These differences may be partly explained by differences in 
population characteristics, organisation of care, or implementation of new 
treatments. The overall prevalence was approximatively of 1.7 per 1,000 livebirths for 
SCPE registries for children born between a three years period. The age at 
confirmation of diagnosis of cerebral palsy is at least 4 years. Therefore, the year of 
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surveillance is 5 to 8 years after birth, depending on the registries. The data should be 
interpreted knowing the context of perinatal health at time of birth. 
 
Table 3. Template for reporting of birth prevalence rate of CP per 1,000 live births and by 
registry in the three years period considered. 
 
Country 
 
SCPE 
centre 
 
Name 
 
National live 
births*  in the  
three years 
period 
considered (#) 
Registry live 
births  in the  
three years 
period 
considered (#) 
Coverage 
of the 
registry  
Nr. of 
CP 
cases 
 
Prevalence 
per 1.000 
live births 
A C0x       
B C0y       
C C0z       
ALL REGISTRIES 
     
* Data from EUROSTAT.  
 
The trends of birth prevalence rates of pre- and perinatal cases of CP per 1,000 live 
births and per year are calculated for all the registries altogether. The number of 
centres included in the calculations may differ according to birth year. The rates are 
presented using a 3-year simple moving average: to smooth out short-term 
fluctuations, prevalence rates are grouped over 3 years, the mean being reported for 
the central year. 
6.2 Type of motor function disorder 
The type of motor function disorder is an indicator of the burden of disease. The 
indicator is presented as distribution of the type of motor disorder, defined by the 
frequency (in %) of the predominant motor function pattern (spasticity – 
unilateral/bilateral, dyskinesia, other patterns i.e., ataxia, mixed forms or unknown), 
calculated for three consecutive birth cohorts combined together reported by each 
registry. 
Only pre- and perinatal cases of CP are included, while CP cases known to be post-
neonatally acquired are excluded. The population considered consist only of 
registries with more than 5 cases reported per year.  
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A Table in the form reported in Table 4 will show the distribution of cerebral palsy 
subtypes that are based on the predominant type of muscle tone or movement 
abnormality.  
The spastic CP, characterised by an increased tone and pathological reflexes, are the 
commonest forms in all registries, affecting more than 80% of the overall cases, with 
a majority of bilateral forms. Hemiplegia (unilateral spastic forms) represents 14% to 
45% of the cases. Dyskinesic CP is characterised by involuntary, uncontrolled, 
recurring, occasionally stereotyped movements of affected body parts. Overall it 
represents 8% of the cases, with wide variations between registries. The ‘Other 
forms’ comprise Ataxic CP with in addition to an abnormal pattern of posture 
and/or movement, a loss of orderly muscular co-ordination, so that movements are 
performed with abnormal force, rhythm and accuracy, as well as Mixed forms when 
no clear dominant clinical feature is observed, and Unclassified patterns. 
 
Table 4. Template for reporting of type of motor dysfunction by registry and overall.  
 
Country 
 
SCPE 
centre 
 
Name 
 
Spastic Bilateral 
(%) 
 
Spastic Unilateral 
(%) 
 
Dyskinetic 
(%) 
 
Other forms 
(%) 
 
A C0x      
B C0y      
C C0z      
ALL REGISTRIES 
    
 
6.3 Walking ability 
The walking ability is an indicator of the burden of disease. It is presented as the 
distribution of walking ability defined by the frequency (in %) of GMFCS (Gross 
Motor Function Classification System) levels: ‘mild’ GMFCS level I-II (independent 
walker), ‘moderate’ GMFCS level III (walker with aid), ‘severe’ GMFCS level IV-V 
(wheelchair). In the calculation three consecutive birth cohorts are combined 
together. As for the previous 2 indicators, also in this case only pre- and perinatal 
cases of CP are included, while CP cases known to be post-neonatally acquired are 
excluded. The population considered consist only of registries covering area with 
3,000 or more livebirths on average during the last 3-years. 
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A bar chart will show the proportion of children with cerebral palsy born between a 
three years period with ‘mild’ (Gross Motor Function Classification System - 
GMFCS level I-II, independent walker), ‘moderate’ (GMFCS level III, walker with 
aid), or ‘severe’ (GMFCS level IV-V, child using a wheelchair) walking 
impairment per registry. The differences in the distribution per registry found in the 
testing dataset may reflect the difficulty to identify the more mildly affected children 
in some regions.  
6.4 Prevalence of severe cases of cerebral palsy 
The prevalence of severe cases is an indicator of the burden of disease. The severity 
of cerebral palsy ranges from minimal to profound, and the likelihood of the co-
occurrence of associated impairments increases with the severity of motor 
impairment. Severe cases are defined by a motor function severely impaired (defined 
by GMFCS= 3 to 5) OR an associated severe intellectual impairment (defined as 
IQ<50).  
This indicator is presented as both: 
 Birth prevalence rate of severe cases of CP per 1,000 live births by registry 
over a 3-years period 
 10-years trend prevalence rates of severe cases of CP per 1,000 live births and 
per year for all the registries altogether. 
A Table in the form reported in Table 5 will show the distribution of birth prevalence 
of severe cases of CP per 1,000 live births for all registries and by registry over a 3-
years period 
A line chart will show the prevalence (per 1,000 live births) of severe cases of cerebral 
palsy over the last ten years, defined by a severely impaired gross motor function 
(GMFCS levels III to V) or the presence of a moderate to profound mental retardation 
(IQ<50). Prevalence is presented using a 3-year simple moving average to smooth out 
short-term fluctuations. 
In the results of the testing analysis, the severe cases accounted for approximately 
one third of the cases. .   
 
Table 5. Template for reporting the birth prevalence of severe cases of CP per 1,000 live 
births and by registry.  
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Country 
 
SCPE 
centre 
 
Name 
 
National 
live births   
Registry 
live births   
Coverage of 
the registry  
Nr. of 
CP 
cases 
 
Prevalence per 
1.000 live births 
A C0x       
B C0y       
C C0z       
ALL REGISTRIES      
 
6.5 Access to neuroimaging 
There is an international consensus that neuroimaging is of great importance in the 
understanding of pathogenesis in relation to timing of brain insult, and to a lesser 
extent aetiology of the brain disorder. It helps understand the deteriorated function. 
Neuroimaging is considered as at least one MRI of the brain whatever the period 
when this imaging occurred. This is an indicator of access to facilities/services. 
Access to neuroimaging is assessed by the proportion (in %) of children with CP who 
have had at least one MRI of the brain during the neonatal period i.e. before 
discharge from the neonatal unit, or later. Registries with less than 5 cases per year 
are excluded from the calculation. Also CP cases known to be post-neonatally 
acquired are excluded.  
A table in the form reported in Table 6 will show this proportion by registry 
calculated for each birth cohort. The results of the testing analysis indicate that the 
proportion of children having has an MRI of the brain varies from 50% to 100% 
across the SCPE registries.  
Table 6. Template for reporting access to neuroimaging by country.  
Country 
 
SCPE 
centre 
 
Name 
 
Access to MRI 
(% of children with CP born) 
Years xxxx-2; xxxx 
A C0x   
B C0y   
C C0z   
ALL REGISTRIES 
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6.6 Prevalence and severity of cerebral palsy of post-neonatal 
origin 
Post-neonatally acquired CP are defined as CP cases with an identified causal event 
independent of antenatal and perinatal periods (mostly after the 28th day of life) 
occurring before 24 months of age. The main underlying causes of brain lesions 
(infections, head injury, surgical complications) are potential targets for preventive 
actions. 
Severe cases are defined by the severity of motor disorder (defined GMFCS= 3 to 5) 
OR associated severe intellectual impairment (defined as IQ<50). 
The prevalence of total cases and of severe cases is shown. These are indicators of 
preventive health strategies. 
Trends of (a) the overall prevalence of post-neonatally acquired CP and of (b) 
prevalence of severe cases (per 10,000 live-births) will be jointly presented.  
According to a literature report2 the combined data from 10 registries showed that 
prevalence rates of CP with an identified post-neonatal cause decreased from 2.05 in 
1976 to 0.41 per 10,000 live births in 1998 (mean prevalence 1.2 per 10,000 live births), 
with an accentuated decrease from 1990.  
 
                                           
2 Germany and coll. in 2013 in Research in Developmental Disabilities 34: 1669-77. 
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7 Conclusions 
The SCPE CDB was rebuilt in the frame of the JRC-SCPE Central Registry and is fully 
functional.  
The calendar of data transmission/data processing was established together with the 
Data Working Group and implemented by the JRC-SCPE Central Registry in 
collaboration with the SCPE registries. It represents now the annual reference for 
updating the CDB.  
Two data collection campaigns were run by the JRC-SCPE Central Registry: 
 June to September 2016 (for the birth year 2007) 
 April to July 2017 (for the birth year 2008). 
In order to extend the use of the CDB data to public health relevant outputs, the JRC-
SCPE Central Registry launched the initiative of developing public health indicators 
in the collaboration with University Hospital of Toulouse, based on the Service 
Contract N° CCR.F.C790682.X0.  
The results of this work are the definition of six public health indicators: 
 Birth prevalence rate of cerebral palsy 
 Type of motor function disorder 
 Walking ability      
 Birth prevalence rate of severe cases of cerebral palsy 
 Access to neuroimaging 
 Prevalence and severity of post-neonatally acquired cerebral palsy 
The CDB was used for the testing of the six public health indicators in two settings: 
 birth-cohorts 2005 – 2007 (data submitted to the CDB between 2014 and 2016); 
 birth-cohorts 1998 – 2007 for 10 years trends calculations.  
This exercise done for the first time at the level of the CDB thus including all 
registries, turned out in the definition of specific inclusion/exclusion criteria for the 
participating registries, in accordance with each public health indicator.  
Interestingly, the number of registries qualifying for the calculation of the six public 
health indicators varies according to the indicator.    
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This first analysis of the newly defined public health indicators applied to the CDB 
has primarily methodological relevance for the JRC-SCPE Central Registry:  
 it  gives valuable insights into the quality / completeness of the data collected; 
 remarkably, a significant number of registries had to be excluded from the 
analysis due to missing variables. In practical terms, this becomes an 
important indicator for the dialogue with and guidance of the registries on the 
inclusion of specific variables into their data collection scheme and data 
validation. 
In the present setting,  
 at least one indicator evaluates preventive health strategies: prevalence and 
severity of post-neonatally acquired cerebral palsy; 
 one indicator relates to the access to specialised medical services: access to 
neuroimaging; 
 the probably widest reaching indicator is the one evaluating the child's long-
term health outcome: birth prevalence rate of cerebral palsy. It provides 
additional information on childhood health across the countries. 
The last three categories of indicators have the potential of generating public health 
relevant conclusions. The analysis and evaluation of these public health indicators in 
the context of the CDB and thus in the SCPE network could generate measures and 
recommendations for medical, healthcare and social services useful for SCPE patients 
and their carers and, in the broader context, for healthcare and social policy 
decisions. This knowledge will help setup services and facilities, increase the family's 
ability to access health services and emphasize the opportunity for preventive public 
health in the field of cerebral palsy.  
In addition, from the EU perspective, they will give some elements for possible 
comparisons between countries/registries and over time involving the health, social 
and political dimensions, including fair access to care. Indeed, prevalence of Cerebral 
Palsy actually reflects different situations across countries in population 
characteristics, prematurity rate, organisation of care, implementation of new 
treatments. A more refined analysis of all these situations may lead to a better 
understanding of the differences recorded between countries / regions and is 
necessary to make useful comparisons which could help in increasing the 
understanding of the impact of improvements in the surveillance of pregnancies, 
neo-natal care and follow-up of vulnerable infants.   
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Annex 1. Template for the Annual feedback to the SCPE 
registries performed by the JRC-SCPE Central 
Registry on the yearly data submission.  
 
  
 33 
1. Introduction 
Text for current year.  
 
2. Not Informative data 
In the following table is reported the percentage of not informative data for every 
item collected in the birth years you submitted.  
The not informative data rate is calculated considering the cases that for every item 
report unknown/not collectable codification or missing value. 
For comparison the rate of not informative data in the central database, calculated on 
all the other registries with data for the same year, is reported. 
For the derived variables, with names aligned on the right, the rate of the not 
informative data is calculated on the expected cases considering the conditioning on 
the primary variables. 
 
 
% OF  NOT INFORMATIVE DATA 
IN YOUR REGISTER 
  % OF  NOT INFORMATIVE DATA 
IN THE CENTRAL DB EXCLUDING 
YOUR REGISTER   
ITEM  
(n° in the guide) 
VARIABLE  
(names) 
Year xx previous year VAR%   Year xx previous year VAR% 
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3. Prevalence rates 
 
3.1 Availability of denominators 
Denominators (A=Available; NA=Not Available) 
 Previous 
year 
year 
Total births 
Stillbirth   
LB   
LB multiple   
NN death   
NN death multiple   
Delivery mode 
Vaginal delivery   
Caesarean section elective/before labour (1)   
Caesarean section emergency/during labour (2)   
Caesarean total (1 + 2)   
Unknown   
Delivery mode per BW 
Vaginal delivery   
Caesarean section elective/before labour (1)   
Caesarean section emergency/during labour (2)   
Caesarean total (1 + 2)   
Delivery mode per GA 
Vaginal delivery   
Caesarean section elective/before labour (1)   
Caesarean section emergency/during labour (2)   
Caesarean total (1 + 2)   
Place of birth 
Distribution of births according to the size of the maternity units   
Home or travel or hospitalisation unit other than maternity unit   
Unknown   
Maternal age and parity 
Maternal age   
Parity   
Neonatal death per BW 
<1000   
1000-1499   
1500-2499   
>2499   
Unknown   
Neonatal death per GA 
<28   
28-31   
32-36   
>36   
Unknown   
Multiple neonatal death per BW 
<1000   
1000-1499   
1500-2499   
>2499   
Unknown   
Multiple neonatal death per GA 
<28   
28-31   
32-36   
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>36   
Unknown   
Live births per BW 
<1000   
1000-1499   
1500-2499   
>2499   
Unknown   
Live births per GA 
<28   
28-31   
32-36   
>36   
Unknown   
Multiple births per BW 
<1000   
1000-1499   
1500-2499   
>2499   
Unknown   
Multiple births per GA 
<28   
28-31   
32-36   
>36   
Unknown 
  
 
 
 
 
 
3.2 Figures describing the prevalence rates since 1990 
Prevalence rates were calculated by excluding post-neonatal cases and children not 
resident at date of birth (or year of registration for C01 and C02) 
Figure1. Prevalence rate in your register  
Figure2. Total prevalence rate including the registries which have submitted cases 
and denominators for the birth year xxxxx 
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4. Distribution of key variables 
Following is reported the distribution of the variables collected for the last year data 
submitted by your register (birth year XXX) compared with the data (XXX-1) present 
in the Central Database on dd/mm/yy. 
 
Column variables: 
CYY= Your centre 
other = other centres (N=K) 
 
variable name: (example of contingency table and chi2 test to evaluate registry's distribution 
of the variable vs distribution of the other registries collapsed) 
 
      sex2 |       YY     others |     Total 
-----------+----------------------+---------- 
    female |         8        348 |       356  
           |     26.67      38.54 |     38.16  
-----------+----------------------+---------- 
      male |        22        555 |       577  
           |     73.33      61.46 |     61.84  
-----------+----------------------+---------- 
     Total |        30        903 |       933  
           |    100.00     100.00 |    100.00  
 
          Pearson chi2(1) =   1.7341   Pr = 0.188 
 
 
Distribution of the variable in your centre years (xxx-4)  - xxx 
 
           |                        BY_YEAR 
      sex2 |      2003       2004       2005       2006       2007 |     Total 
-----------+-------------------------------------------------------+---------- 
    female |        22         22         13         18          8 |        83 
           |     41.51      50.00      41.94      37.50      26.67 |     40.29 
-----------+-------------------------------------------------------+---------- 
      male |        31         22         18         30         22 |       123 
           |     58.49      50.00      58.06      62.50      73.33 |     59.71 
-----------+-------------------------------------------------------+---------- 
     Total |        53         44         31         48         30 |       206 
           |    100.00     100.00     100.00     100.00     100.00 |    100.00 
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Annex 2.  SCPE Public Health Indicators - Summary of the 
programme for the DATA SET UP in Stata 
                
********************************************************************** 
***************    SCPE Public Health Indicators                      ***************** 
***************    DATA PREPARATION                                   ***************** 
***************    version 1, 20th november 2017                   ***************** 
*********************************************************************** 
* Author : Virginie Ehlinger 
* Date of last update: 20th november 2017 
* Software : Stata 14.2 SE.  
* Needs installation of Stata "sencode" package (http://fmwww.bc.edu/RePEc/bocode/s/) 
* Program name : SCPE public_health_indicators data_preparation v1.do 
********************************************************************* 
 
* Program organization: 
* Data preparation: individual data on CP children 
* a) Importing individual data stored in txt format with ";" delimiter 
*   b) List of birth year considered for analysis 
*   c) Variables creation  
*   d) Save the prepared data (Stata format) 
* Data preparation: aggregated data to estimate prevalences 
*    a) Opening individual data on CP children  
*    b) Generating aggregated database on CP children: 
*    c) Merging with denominator data  
*    d) Birth-cohorts: variables creation  
*    e) Number of livebirths: variables creation  
*    f) Number of cases   
*    g) Proportion of missing values   
*    h) Inclusion/exclusion criteria 
*    i) Prevalence rates computation 
*    j) Save the prepared aggregated data   
*  k) Smoothed prevalence rates using 3-years moving averages for 
the last 10 years, all registries 
*    l) Insert sampling variables in the individual database 
 
 
* List of tables generated: 
* "$scpe_db prepared_$today": individual data on CP children 
* "scpe_aggregated_data prepared_$today": aggregated data (by year and registry), 
numerators and denominators 
* "scpe_aggregated_data_pre_peri_10y_all prepared_$today": aggregated data (by 
year), numerators and denominators for pre-/peri-natal CP 
* "scpe_aggregated_data_pre_peri_severe_10y_all prepared_$today": aggregated data 
(by year), numerators and denominators for severe pre-/peri-natal CP 
* "scpe_aggregated_data_postneon_10y_all prepared_$today": aggregated data (by 
year), numerators and denominators for post-neonatal CP 
* "scpe_aggregated_data_postneon_severe_10y_all prepared_$today": aggregated data 
(by year), numerators and denominators for severe post-neonatal CP 
 
* #################################################### 
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* Global variables: The use change the global variable (but not their names) 
* 1/ Date of the analysis 
 global today = c(current_date) 
 
* 2/ Input: filename and directory name of the databases (individual SCPE data, 
denominator data) 
  
  
* 3/ Input : last year considered for the analysis : 
 global last_year = 2007 // to be modified by user 
* 
####################################################### 
 
 
********************************************************************** 
*--------------------- Data preparation: individual data on CP children 
********************************************************************** 
 
 
* a) Importing individual data stored in txt format with ";" delimiter 
   
 
 * DESCRIPTION OF CEREBRAL PALSY 
 lab var cp_type  "CP classification 1" 
  lab var spas_type "CP classification 2 (refers to spastic CP)" 
 lab var intel_imp "Intellectual impairment" 
  lab var gmfcs "Gross Motor Function Classification (GMFCS)" 
  
 
 * POSTNEONATAL CEREBRAL PALSY 
 lab var postneon  "Postneonatal CP" 
 lab var postn_code1 "Coding diagnosis for Postneonatal" 
 lab var postn_code2 "Text diagnosis for Postneonatal" 
 lab var age_postn "Age at the time of the insult (if postneonatal)" 
 
 * NEUROIMAGING 
 lab var imaging "Has imaging been performed" 
 lab var post_imag "Postneoatal imaging" 
 lab var mri "MRI" 
 lab var mri_age "Chronological age at the more recent postneonatal imaging" 
 lab var mri_result "Classification of MRI results" 
 lab var mri_side "Side of this imaging result" 
 lab var neoni "Has imaging been performed before discharge from NCU" 
 lab var neoni_age "Chronological age at the more recent neonatal imaging" 
 lab var neoni_result "Classification of neonatal imaging results" 
 lab var neoni_r_txt "Clear text for the neonatal imaging result (English)" 
 lab var neoni_side "Side of this neonatal imaging result" 
  
  
* b) List of birth year considered for analysis 
 * List of the 3 years of analysis 
 * List of the 10 years of analysis 
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* c) Variables creation  
 * Country 
 * registry with label containing country name 
 * Type of motor function disorder 
 * CP case 
 * CP case, excluding post-neonatally acquired CP 
 * post-neonatally acquired CP 
 * severe post-neonatally acquired CP 
 * birth-cohort  
 * Missing/unknown GMFCS, excluding post-neonatally acquired CP 
  * Missing/unknown INTEL_IMP, excluding post-neonatally acquired CP 
  * Case of severe CP during the last three years, excluding post-neonatally acquired    
   CP 
 * Missing/unknown GMFCS, in post-neonatally acquired CP 
 * Missing/unknown GMFCS, in post-neonatally acquired CP 
  * Missing value on access to neuroimaging, in post-neonatally acquired CP 
 * sample used to analyze CP characteristics during the last 3 years period 
 * sample used to analyze CP characteristics during the last 10 years period 
 * sample used to analyze characteristics of post-neonatally acquired CP 
    
* d) Save the prepared data  
  
*************************************************************** 
*    Data preparation: aggregated data to estimate prevalences 
**************************************************************** 
  
* a) Opening individual data on CP children  
 
* b) Generating aggregated database on CP children 
 
* c) Merging with denominator data  
 
* d) Birth-cohorts: variables creation  
 * first year with non-missing number of collected CP cases  
 * last year with non-missing number of collected CP cases  
 * first year with non-missing number of livebirths  
 * last year with non-missing number of livebirths  
 
* e) Number of livebirths: variables creation  
 *Number of livebirths per registry during the 3-year period 
 * Average number of livebirths per year and per registry during the 3-year period 
 
* f) Number of cases   
 * number of pre-/peri-natally acquired CP (excluding post-neonatally acquired CP) 
within the last 3 years period 
 * number of severe pre-/peri-nataly acquired CP (excluding post-neonatally 
acquired CP) within the last 3 years period 
 * number of severe pre-/peri-nataly acquired CP (excluding post-neonatally 
acquired CP) within the last 3 years period 
 
* g) Proportion of missing values   
 * Maximum proportion of missing data in the last three years 
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* h) Inclusion/exclusion criteria 
 * Six sampling variables are generated: 
 * Sample for analysis of CP prevalence excluding post-neonatal cases, birth-
cohorts  
 * Sample for analysis of severe CP prevalence excluding post-neonatal cases, 
birth-cohorts  
 *Sample for analysis of CP prevalence excluding post-neonatal cases, birth-cohorts  
 *Sample for analysis of severe CP prevalence excluding post-neonatal cases, birth-
cohorts  
 * Sample for analysis of post-neonatal CP prevalence, birth-cohorts  
 * Sample for analysis of severe post-neonatal CP prevalence, birth-cohorts  
  
* No numerator or 0 case of CP, per year and per registry 
* No numerator or 0 case of CP for at least one year within birth-cohorts  
* No numerator or 0 post-neonatal case of CP for at least one year within birth-
cohorts  
* No denominator (livebirths), per year and per registry 
 * (cases of CP exclude post-neonatally acquired CP)  
* No denominator for at least one year within birth-cohorts  
* Less than 3,000 livebirths per year and per registry  
* Less than 3,000 livebirths per year on average in the registry during the 3-year 
period 
* sample used to analyze CP prevalences (excluding post-neonatally acquired CP) 
within the last 3 years period 
* sample used to analyze severe CP prevalences (excluding post-neonatally 
acquired CP) in the last 3 years period  
* sample used to analyze CP prevalences (excluding post-neonatally acquired CP) 
in the last 10 years period 
* sample used to analyze severe CP prevalences (excluding post-neonatally 
acquired CP) during the last 10 years period 
* sample used to analyze post-neonatally acquired CP prevalences during the last 
10 years period 
* sample used to analyze severe post-neonatally acquired CP prevalences during 
the last 10 years period 
* Total number of pre-/peri-neonatal CP cases (all registries) during the last 10 
years 
* Total number of severe pre-/peri-neonatal CP cases (all registries) during the last 
10 years 
* Total number of post-neonatal CP cases (all registries) during the last 10 years 
* Total number of severe post-neonatal CP cases (all  
* Total number of livebirths (all registries) during the last 10 years 
* Total number of livebirths (all registries) during the last 10 years 
* Total number of livebirths (all registries) during the last 10 years 
* Total number of livebirths (all registries) during the last 10 years 
   
* i) Prevalence rates computation 
* Birth prevalence per year and per registry (/1000 livebirths) including post-
neonatally acquired CP 
* Birth prevalence of cases of CP per year and per registry (/1000 livebirths) 
excluding post-neonatally acquired CP 
* Birth prevalence per year and per registry (/1000 livebirths) for post-neonatally 
acquired CP 
* Birth prevalence during the 3 last years, per registry (/1000 livebirths) 
* Birth prevalence rate of severe CP, per year of birth and registry (/1000 
livebirths) excluding post-neonatally acquired CP 
* Birth prevalence rate of severe CP, per year of birth and registry (/1000 
livebirths) excluding post-neonatally acquired CP within 3 years 
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* Birth prevalence rate of pre-/peri-neonatal CP cases (all registries) during the last 
10 years   => 1 estimation per year, all registries 
* Birth prevalence rate of pre-/peri-neonatal severe CP cases (all registries) during 
the last 10 years  => 1 estimation per year, all registries 
* Birth prevalence rate of severe CP, per year of birth and registry (/10000 
livebirths) for severe post-neonatally acquired CP 
* Birth prevalence rate of post-neonatal CP cases (all registries) during the last 10 
years  => 1 estimation per year, all registries 
* Birth prevalence rate of post-neonatal CP cases (all registries) during the last 10 
years  => 1 estimation per year, all registries 
  
   
* j) Save the prepared aggregated data   
   
  
 k) Smoothed prevalence rates using 3-years moving averages for the last 10 
years, all registries 
  
* Table: Aggregated data, all registries: Birth prevalence rate of pre-/peri-neonatal 
CP per 1,000 LB 
   
* Table: Aggregated data, all registries: Birth prevalence rate of severe pre-/peri-
neonatal CP per 1,000 LB 
   
* Table: Aggregated data, all registries: Birth prevalence rate of severe post-
neonatal CP per 10,000 LB 
 
* Table: Aggregated data, all registries: Birth prevalence rate of severe post-
neonatal CP per 10,000 LB 
   
 
* l) Insert sampling variables in the individual database 
  
  
 
  
42 
Annex 3. Summary of the programme for the calculation 
of SCPE Public Health Indicators in Stata 
*********************************************************************** 
*****************        SCPE Public Health Indicators                 ***************** 
*****************         version 1, 20th November 2017            ***************** 
*********************************************************************** 
* Author: Virginie Ehlinger
* Date of last update: 20th November 2017
* Software: Stata 14.2 SE.
* Needs installation of Stata "estout" package (http://repec.org/bocode/e/estout)
* Program name: SCPE public_health_indicators v1.do
* Program organization:
* 0. Generating output file 
* 1. SCPE Public Health Indicator n#1: Prevalence rate of cerebral palsy 
* 2. SCPE Public Health Indicator n#2: Type of motor function disorder 
* 3. SCPE Public Health Indicator n#3: Walking ability 
* 4. SCPE Public Health Indicator n#4: Birth prevalence rate of severe cases of cerebral 
palsy 
* 5. SCPE Public Health Indicator n#5: Access to neuroimagin 
* 6. SCPE Public Health Indicator n#6: Prevalence and severity of post-neonatally 
acquired CP 
* Graphs generated:
* "SCPE_PHI_1_1_$today.wmf": Birth prevalence rate of CP per 1,000 live births and per
year, all registries 
* "SCPE_PHI_3_1_$today.wmf": Walking ability by registry
* "SCPE_PHI_4_1_$today.wmf": Birth prevalence rate of severe CP per 1,000 live births
and per year 
* "SCPE_PHI_6_1_$today.wmf": Birth prevalence rate of post-neonatally acquired CP per
10,000 live births 
* "SCPE_PHI_6_2_$today.wmf": Birth prevalence rate of severe post-neonatally acquired
CP per 10,000 live births 
GETTING IN TOUCH WITH THE EU 
In person 
All over the European Union there are hundreds of Europe Direct information centres. You can find the 
address of the centre nearest you at: http://europea.eu/contact 
On the phone or by email 
Europe Direct is a service that answers your questions about the European Union. You can contact this 
service: 
- by freephone: 00 800 6 7 8 9 10 11 (certain operators may charge for these calls), 
- at the following standard number: +32 22999696, or 
- by electronic mail via: http://europa.eu/contact 
FINDING INFORMATION ABOUT THE EU 
Online 
Information about the European Union in all the official languages of the EU is available on the Europa 
website at: http://europa.eu 
EU publications 
You can download or order free and priced EU publications from EU Bookshop at: 
http://bookshop.europa.eu. Multiple copies of free publications may be obtained by contacting Europe 
Direct or your local information centre (see http://europa.eu/contact). 
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